LON:AGL

ANGLE (AGL) Share Price, News & Analysis

GBX 17.75
+4.00 (+29.09%)
(As of 05/3/2024 ET)
Today's Range
15.06
18.30
50-Day Range
11.75
17.75
52-Week Range
9.07
37.40
Volume
7.20 million shs
Average Volume
3.13 million shs
Market Capitalization
£46.25 million
P/E Ratio
N/A
Dividend Yield
1.12%
Price Target
GBX 70

ANGLE MarketRank™ Stock Analysis

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
294.4% Upside
GBX 70 Price Target
Short Interest
N/A
Dividend Strength
Weak
Based on Four Factors
Sustainability
N/A
News Sentiment
0.41mentions of ANGLE in the last 14 days
Based on 4 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
N/A

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

1.26 out of 5 stars

AGL stock logo

About ANGLE Stock (LON:AGL)

ANGLE plc, a medical diagnostic company, engages in developing cancer diagnostics products in Europe, North America, and the United Kingdom. The company develops and commercializes Parsortix cell separation system, which captures and harvests circulating tumor cells in metastatic breast cancer patient blood; and HyCEAD. ANGLE plc has a partnership agreement with Bio View Ltd to develop a liquid biopsy circulating tumor cell HER2 assay for breast cancer. The company was founded in 1994 and is based in Guildford, the United Kingdom.

AGL Stock Price History

AGL Stock News Headlines

AstraZeneca contract puts Angle in spotlight
The Gold Grab of the Century
When central banks buy gold… The rich buy right along with them. And central banks are buying at breakneck pace. Last year… 1,037 tons. Just 45 tons less than the record set two years ago.
ANGLE (LON:AGL) Stock Price Up 16.4%
ANGLE (LON:AGL) Given Buy Rating at Berenberg Bank
Angles, lines and polygons - Edexcel
The Gold Grab of the Century
When central banks buy gold… The rich buy right along with them. And central banks are buying at breakneck pace. Last year… 1,037 tons. Just 45 tons less than the record set two years ago.
Angle PLC Announces Breakthrough Clinical Results
ANGLE Plc Signs Contract With Eisai - Quick Facts
Angle PLC - Contract announcement with Eisai Inc.
Angle PLC Announces Broker Announcement
Angles and triangles
ANGLE launches Portrait+ CTC kit at SABCS
ANGLE unveils new detailed cancer diagnostic
See More Headlines
Receive AGL Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for ANGLE and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
1/30/2020
Today
5/05/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Diagnostics & Research
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
173
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
GBX 70
High Stock Price Target
GBX 70
Low Stock Price Target
GBX 70
Potential Upside/Downside
+294.4%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

Net Income
£-22,280,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
£1.82 million
Cash Flow
GBX 3.06 per share
Book Value
GBX 12 per share

Miscellaneous

Free Float
N/A
Market Cap
£46.25 million
Optionable
Not Optionable
Beta
0.12
Investing Strategies To Help Grow Your Retirement Income Cover

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report

Key Executives

  • Mr. Andrew David William Newland ACA (Age 63)
    Meng, Founder, CEO & Executive Director
    Comp: $264k
  • Mr. Ian Francis Griffiths ACA (Age 60)
    BA, CFO, Finance Director, Company Secretary & Executive Director
    Comp: $164k
  • Mr. Martin Cooke (Age 55)
    Director of Operations & Regulatory Affairs
  • Dr. Karen Miller Ph.D.
    Chief Scientific Officer
  • Mr. Andrew John Holder (Age 56)
    Head of Investor Relations
  • Ms. Anne-Sophie Pailhes-Jimenez
    Head of R&D and Senior Director
  • Mr. Brett Swansiger
    Chief Commercial Officer
  • Mr. Nick Claxton
    Senior Vice President of Commercial Operations

AGL Stock Analysis - Frequently Asked Questions

Should I buy or sell ANGLE stock right now?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for ANGLE in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" AGL shares.
View AGL analyst ratings
or view top-rated stocks.

What is ANGLE's stock price target for 2024?

1 equities research analysts have issued twelve-month target prices for ANGLE's shares. Their AGL share price targets range from GBX 70 to GBX 70. On average, they predict the company's stock price to reach GBX 70 in the next twelve months. This suggests a possible upside of 294.4% from the stock's current price.
View analysts price targets for AGL
or view top-rated stocks among Wall Street analysts.

How have AGL shares performed in 2024?

ANGLE's stock was trading at GBX 11.75 at the start of the year. Since then, AGL stock has increased by 51.1% and is now trading at GBX 17.75.
View the best growth stocks for 2024 here
.

How were ANGLE's earnings last quarter?

ANGLE plc (LON:AGL) announced its quarterly earnings results on Thursday, January, 30th. The company reported ($3.33) earnings per share for the quarter.

What other stocks do shareholders of ANGLE own?

Based on aggregate information from My MarketBeat watchlists, some companies that other ANGLE investors own include Yamana Gold (YRI), Asiamet Resources (ARS), Dekel Agri-Vision (DKL), Eldorado Gold (ELD), Polo Resources (POL), Silvercorp Metals (SVM), First Majestic Silver (AG), AFPO.L (AFPO), Ariana Resources (AAU) and Alamos Gold (AGI).

How do I buy shares of ANGLE?

Shares of AGL stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

This page (LON:AGL) was last updated on 5/5/2024 by MarketBeat.com Staff

From Our Partners